Mecamylamine interactions with galantamine and donepezil: effects on learning, acetylcholinesterase, and nicotinic acetylcholine receptors (Q44340367)

2 December 2017

Mecamylamine interactions with galantamine and donepezil: effects on learning, acetylcholinesterase, and nicotinic acetylcholine receptors (English)

1 reference

2 December 2017

Woodruff-Pak DS

1

1 reference

2 December 2017

Vogel RW 3rd

series ordinal

2

1 reference

2 December 2017

Wenk GL

series ordinal

3

1 reference

2 December 2017

language of work or name

English

0 references

publication date

1 January 2003

1 reference

2 December 2017

1 reference

2 December 2017

117

1 reference

2 December 2017

2

1 reference

2 December 2017

439-447

1 reference

Chronic treatment of old rats with donepezil or galantamine: effects on memory, hippocampal plasticity and nicotinic receptors.

2 December 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2802%2900872-2

7 January 2021

Alzheimer's Disease: A Disorder of Cortical Cholinergic Innervation

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2802%2900872-2

7 January 2021

A new and rapid colorimetric determination of acetylcholinesterase activity

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2802%2900872-2

7 January 2021

Differential regulation of neuronal nicotinic receptor binding sites following chronic nicotine administration.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2802%2900872-2

7 January 2021

Cholinesterase inhibition by galanthamine and lycoramine

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2802%2900872-2

7 January 2021

Nicotinic systems and cognitive function

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2802%2900872-2

7 January 2021

beta -Amyloid peptide blocks the response of alpha 7-containing nicotinic receptors on hippocampal neurons

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2802%2900872-2

7 January 2021

Allosteric sensitization of nicotinic receptors by galantamine, a new treatment strategy for Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2802%2900872-2

7 January 2021

Allosterically potentiating ligands of nicotinic receptors as a treatment strategy for Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2802%2900872-2

7 January 2021

Alpha4 but not alpha3 and alpha7 nicotinic acetylcholine receptor subunits are lost from the temporal cortex in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2802%2900872-2

7 January 2021

Kinetic study on the inhibition of acetylcholinesterase by 1-benzyl-4-[(5,6-dimethoxy-1-indanon)-2-yl]methylpiperidine hydrochloride (E2020).

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2802%2900872-2

7 January 2021

Nicotinic receptor abnormalities of Alzheimer's disease: therapeutic implications.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2802%2900872-2

7 January 2021

beta-Amyloid(1-42) peptide directly modulates nicotinic receptors in the rat hippocampal slice.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2802%2900872-2

7 January 2021

The septohippocampal cholinergic system and classical conditioning of the rabbit's nictitating membrane response

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2802%2900872-2

7 January 2021

Disruption of classical conditioning in patients with Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2802%2900872-2

7 January 2021

Altered activity in the hippocampus is more detrimental to classical conditioning than removing the structure.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2802%2900872-2

7 January 2021

Physostigmine, galanthamine and codeine act as ‘noncompetitive nicotinic receptor agonists’ on clonal rat pheochromocytoma cells

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2802%2900872-2

7 January 2021

Tacrine interacts with an allosteric activator site on alpha 4 beta 2 nAChRs in M10 cells

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2802%2900872-2

7 January 2021

Organization of memory traces in the mammalian brain

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2802%2900872-2

7 January 2021

Selective inhibition of human acetylcholinesterase by galanthamine in vitro and in vivo.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2802%2900872-2

7 January 2021

Differences in the pattern of hippocampal neuronal loss in normal ageing and Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2802%2900872-2

7 January 2021

Expression of nicotinic acetylcholine receptors in Alzheimer's disease: postmortem investigations and experimental approaches.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2802%2900872-2

7 January 2021

Mecamylamine- or scopolamine-induced learning impairment: ameliorated by nefiracetam.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2802%2900872-2

7 January 2021

Alzheimer's disease and eyeblink conditioning: 750 ms trace vs. 400 ms delay paradigm.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2802%2900872-2

7 January 2021

Eyeblink classical conditioning in Alzheimer's disease and cerebrovascular dementia.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2802%2900872-2

7 January 2021

Galantamine: Effect on nicotinic receptor binding, acetylcholinesterase inhibition, and learning

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2802%2900872-2

7 January 2021

Nicotinic cholinergic system involvement in eyeblink classical conditioning in rabbits.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2802%2900872-2

7 January 2021

10.1016/S0306-4522(02)00872-2

Identifiers

DOI

1 reference

2 December 2017

1 reference